Capricor Therapeutics Inc (CAPR)
Capricor Therapeutics Market Cap: 197.23M for May 17, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
May 17, 2024 | 197.23M |
May 16, 2024 | 179.42M |
May 15, 2024 | 169.56M |
May 14, 2024 | 165.42M |
May 13, 2024 | 173.05M |
May 10, 2024 | 167.48M |
May 09, 2024 | 171.27M |
May 08, 2024 | 169.69M |
May 07, 2024 | 172.54M |
May 06, 2024 | 174.75M |
May 03, 2024 | 172.85M |
May 02, 2024 | 165.58M |
May 01, 2024 | 168.43M |
April 30, 2024 | 166.53M |
April 29, 2024 | 168.43M |
April 26, 2024 | 170.96M |
April 25, 2024 | 162.74M |
April 24, 2024 | 159.26M |
April 23, 2024 | 152.31M |
April 22, 2024 | 156.10M |
April 19, 2024 | 158.32M |
April 18, 2024 | 159.58M |
April 17, 2024 | 175.38M |
April 16, 2024 | 187.39M |
April 15, 2024 | 185.18M |
Date | Value |
---|---|
April 12, 2024 | 197.50M |
April 11, 2024 | 196.87M |
April 10, 2024 | 199.08M |
April 09, 2024 | 208.56M |
April 08, 2024 | 207.93M |
April 05, 2024 | 212.35M |
April 04, 2024 | 211.72M |
April 03, 2024 | 214.88M |
April 02, 2024 | 217.73M |
April 01, 2024 | 224.20M |
March 28, 2024 | 213.91M |
March 27, 2024 | 213.28M |
March 26, 2024 | 198.78M |
March 25, 2024 | 208.86M |
March 22, 2024 | 200.99M |
March 21, 2024 | 216.74M |
March 20, 2024 | 215.80M |
March 19, 2024 | 213.91M |
March 18, 2024 | 212.96M |
March 15, 2024 | 200.64M |
March 14, 2024 | 193.74M |
March 13, 2024 | 186.51M |
March 12, 2024 | 185.26M |
March 11, 2024 | 182.12M |
March 08, 2024 | 184.94M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
Sarepta Therapeutics Inc | 12.42B |
PTC Therapeutics Inc | 2.538B |
Solid Biosciences Inc | 343.50M |
Inovio Pharmaceuticals Inc | 310.93M |
Stereotaxis Inc | 173.55M |
Market Cap Related Metrics
PS Ratio | 6.476 |
Price to Book Value | 10.70 |
Price | 6.20 |
Earnings Yield | -13.39% |